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Few studies have investigated the many mosquito spe-
cies that harbor arboviruses in Kenya. During the 2006–
2007 Rift Valley fever outbreak in North Eastern Province, 
Kenya, exophilic mosquitoes were collected from home-
steads within 2 affected areas: Gumarey (rural) and Sogan-
Godud (urban). Mosquitoes (n = 920) were pooled by trap 
location and tested for Rift Valley fever virus and West Nile 
virus. The most common mosquitoes trapped belonged to 
the genus Culex (75%). Of 105 mosquito pools tested, 22% 
were positive for Rift Valley fever virus, 18% were positive 
for West Nile virus, and 3% were positive for both. Esti-
mated mosquito minimum infection rates did not differ be-
tween locations. Our data demonstrate the local abundance 
of mosquitoes that could propagate arboviral infections in 
Kenya and the high prevalence of vector arbovirus positivity 
during a Rift Valley fever outbreak. 
E
merging zoonotic diseases threaten the health and se-
curity of human and animal populations throughout 
the world (1). Because arthropod-borne viruses, or arbovi-
ruses, can be spread by competent mosquito vectors across 
great distances, they pose substantial risk to other regions 
in which the disease is currently nonendemic (1). Zoonotic 
arboviruses circulate in sylvatic and peridomestic cycles 
involving wild animals and nearby humans. Often these ar-
boviruses remain undetected by health care systems (2–4). 
Kenya has had multiple arbovirus outbreaks in the past 2 
decades resulting in economic and public health distress, 
including yellow fever in 1992 (5,6) and 1995 (7), chikun-
gunya fever in 2004 (8), and Rift Valley fever (RVF) in 
1997 (9) and 2006 (10). Much remains unknown about the 
true prevalence of arboviruses in Kenya and the mosquito 
vectors responsible for virus maintenance and transmis-
sion. We investigated the local abundance of mosquitoes in 
Kenya that are infected with RVF virus (RVFV) and West 
Nile virus (WNV); mosquitoes were collected near human 
habitation during a period of prolonged heavy rainfall.
Rift Valley fever virus, family Bunyaviridae, genus 
Phlebovirus, is a vector-borne virus endemic to Africa and 
the Middle East (11). Recent outbreaks of RVF have re-
sulted in substantial human illness and livestock losses in 
Kenya (9,10,12). Domestic ungulates are a principal source 
of transmissible RVFV, and human infection has been as-
sociated with direct animal contact, speciﬁ  cally with cattle, 
sheep, and goats (2,9,12). It is unclear which, if any, animal 
species maintain RVFV during interepidemic periods, and 
it is possible that RVFV is maintained solely within arthro-
pod vectors during these periods (13). 
West Nile virus, family Flaviviridae, genus Flavivirus, 
is a vector-borne virus that is maintained in nature between 
mosquitoes and birds (11). Humans and other mammals are 
incidental hosts and do not play a role in the natural pres-
ervation of WNV (11). Because most WNV infections are 
self-limiting and subclinical, human infections in Kenya 
are often misdiagnosed (14). As a result, the true preva-
lence of WNV in the country is probably underestimated 
(15). Further clariﬁ  cation of the true presence and circula-
tion of WNV in mosquito vectors could enhance human 
WNV case detection in the region.
Few studies have investigated the many mosquito spe-
cies that harbor arboviruses in Kenya (16–21). Entomolog-
ic surveys have demonstrated that mosquitoes that usually 
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facilitate outbreaks of arboviral diseases, speciﬁ  cally Ae-
des spp., Anopheles spp., and Culex spp., ﬂ  ourish in Kenya 
(16,18,19,22–26). At least 40 different mosquito species 
can harbor RVFV, although their ability to transmit RVFV 
varies (14,20,21,27–29). Furthermore, although many spe-
cies are susceptible to RVFV infection, studies of mosquito 
vectors in northeastern Kenya have shown that the propor-
tion of positivity in individual species differs greatly (5.9% 
An. squamosus, 30% Ae. ochraceus, 42% Ae. mcintoshi) 
(R. Sang, pers. comm.). RVFV can also be transovarially 
transmitted in at least 1 mosquito species, Ae. mcintoshi 
(17). The isolation of WNV from a non–blood-feeding 
male  Cx. univattatus mosquito trapped in northwestern 
Kenya indicates that WNV also transmits transovarially in 
that region (23).
Materials and Methods
Sampling
To evaluate the temporal proﬁ  le of vector mosquitoes 
in North Eastern Province, Kenya, trapping was performed 
during the dry season (August 2006) and during the rainy 
season (December 2006–January 2007). Mosquitoes col-
lected during December 2006 and January 2007 were 
trapped during an epizootic/epidemic of RVF. Homestead 
trapping locations adjacent to homesteads in the regions 
were randomly selected from previously prepared census 
lists and were restricted to only those homes where ani-
mals (cows, goats, or sheep) were housed alongside human 
habitats. Each household had only 1 CDC light trap (John 
W. Hock Company, Gainesville, FL, USA) located next to 
animal structures; trap was set 1 time for 12 hours, 6:00 
PM–6:00 AM. 
Mosquito sampling was conducted in 2 areas within 
Masalani Division, Ijara District, North Eastern Province, 
where human surveillance had taken place 8 months before 
the RVF outbreak (2) (Figure 1). Traps were located in the 
rural village of Gumarey (1°40′12′′S, 40°10′48′′E) and the 
town of Sogan-Godud (1°41′24′′S, 40°10′12′′E). The popu-
lation of Gumarey consists of seminomadic herders who 
live in traditional grass huts near their livestock. Sogan-
Godud is more urban with a marketplace and contains a 
greater proportion of tin-roofed permanent dwellings. The 
centroids of these 2 locations are 5 km apart, and the bor-
ders are within 500 m of each other. Both locations had per-
sistent local ﬂ  ooding during the extensive El Niño/South-
ern Oscillation associated heavy rains during 2006–2007, 
and both are within 10 km of the Tana River. Persons se-
ropositive for RVFV from both locations were documented 
in early 2006; seroprevalence rates were greater in rural 
Gumarey (20% vs. 6%) (2). During that initial study, all 
homesteads were identiﬁ  ed and their locations identiﬁ  ed 
by Global Positioning Satellite. Spatially referenced data 
on individual residence and homestead exposure features 
were maintained and analyzed by using ArcGIS version 9.2 
(ESRI, Redlands, CA, USA).
Mosquito Preparation
Mosquito genera were identiﬁ  ed in Kenya by local en-
tomologists on the basis of microscopic morphologic ap-
pearance. Only female mosquitoes were included in this 
study; male mosquitoes were not further tested. Single leg 
specimens were preserved in RNAlater (Ambion, Austin, 
TX, USA) and transported to Case Western Reserve Uni-
versity (Cleveland, OH, USA) for processing. DNA and 
RNA were extracted from mosquito legs by using a column 
puriﬁ  cation kit (QIAGEN, Valencia, CA, USA) with the 
following modiﬁ  cations: each mosquito leg was placed into 
a microcentrifuge tube containing 150 μL of RNeasy lysis 
buffer and ﬁ  nely ground with a disposable RNase/DNase-
free pestle. After homogenization, samples were processed 
according to established protocols through either individual 
QIAGEN RNeasy columns or 96-well plates, washed, and 
eluted in RNase-free water. The DNase step was omitted 
so that DNA and RNA could be collected from samples. 
Individual RNA samples were combined in pools of <12 
mosquitoes (median 10, mean 8.7), based on homestead 
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Figure 1. Location of Masalani Division of Ijara District, North 
Eastern Province, Kenya.Arbovirus Prevalence in Mosquitoes, Kenya
trap for cDNA synthesis and PCR or quantitative reverse 
transcription–PCR (qRT-PCR).
Primers and Generation of Standard Controls
To verify the quality of the RNA and the integrity of 
the cDNA products after reverse transcription, mosquito 
18S rRNA primers were designed to amplify within a re-
gion conserved in many Culicidae spp. mosquitoes (30). 
These mosquito primers were designed against the 18S 
rRNA gene sequences for Aedes spp. (GenBank accession 
no. AB085210) and Culex spp. (GenBank accession no. 
U48385) mosquitoes to amplify an optimally sized prod-
uct (124 bp) for qRT-PCR. WNV primers were based on 
the New York 1999 WNV isolate (GenBank accession 
no. AF196835.2) described by Lanciotti et al. (11). These 
primers have been shown to detect Old and New World 
WNV strains, including a strain isolated in Kenya in 1998 
(11,31). RVFV primers, which amplify a conserved region 
of the large segment (90 bp), were used as described by 
Bird et al. (32) (Table 1).
An RVFV standard control was generated by amplify-
ing RVFV vaccine strain rMP-12 in Vero E6 cells for 72 
h and then extracting viral RNA from supernatant and cell 
lysate by using the PureLink Total RNA Puriﬁ  cation System 
(Invitrogen, Carlsbad, CA, USA). A WNV standard control 
was generated by using conﬁ  rmed WNV-positive samples 
received from the Ohio Department of Health. Mosquito 
18S rRNA-, WNV-, and RVFV-positive controls were gen-
erated by using the primers listed in Table 1 and cloned by 
using the pCR 8/GW/TOPO TA cloning kit (Invitrogen). 
All inserts were veriﬁ  ed by sequencing of the plasmids.
cDNA Synthesis, PCR, and qRT-PCR Conditions
Two-step qRT-PCR was performed on all pooled 
samples. First-step total cDNA synthesis was performed on 
RNA extracted from mosquito leg tissue by using random 
hexamer primers. The reaction mixture was incubated at 
65°C for 5 min, chilled on ice, and combined with 4 μL 5× 
First-Strand Buffer, 1 μL 0.1M dithiothreitol, 1 μL RNase 
inhibitor, and 0.5 μL SuperScript III Reverse Transcriptase 
(Invitrogen). The ﬁ  nal reaction mixture was incubated at 
25°C for 10 min, 50°C for 50 min, and heat inactivated at 
70°C for 15 min.
After cDNA synthesis, 1 μL of total cDNA was added 
to the qRT-PCR mixture containing 0.2 μmol/L forward 
primer and 0.2 μmol/L reverse primer (18S and WNV test-
ing), 12 μL FastStart Universal SYBR Green Master mix 
(Roche, Indianapolis, IN, USA), and 12 μL sterile, nucle-
ase-free water. The qRT-PCR was conducted in an Applied 
Biosystems 7300 instrument (Applied Biosystems, Foster 
City, CA, USA) with a heating cycle of 50°C for 2 min and 
95°C for 10 min; followed by 45 cycles of 95°C for 15 s, 
60°C for 1 min, 95°C for 15 s; and an additional dissocia-
tion step of 60°C for 1 min. All samples, which registered 
a cycle threshold value <35 cycles and had a lower cycle 
threshold value than negative controls, were considered 
positive for their respective targets. All pools were further 
PCR tested for RVFV by using 2 μL cDNA, 0.5 μmol/L 
each forward/reverse RVFV primer, 10.5 μL sterile, nucle-
ase-free water, and 12.5 μL JumpStart ReadyMix Taq (Sig-
ma-Aldrich, St. Louis, MO, USA). PCR cycling parameters 
were 94°C for 5 min, with 30 cycles of 95°C for 30 s, 60°C 
for 1 min, 72°C for 1 min, and a 10-min 72°C extension. 
PCR products were run on a 2% agarose gel with SYBR 
Safe (Invitrogen) for band visualization (Figure 2). An ini-
tial sampling of RVFV PCR products was cloned by using 
the above-mentioned methods and sequenced for conﬁ  rma-
tion. Mosquito minimum infection rates (MIR) for RVFV 
and WNV were calculated on the basis of maximum-like-
lihood estimation by using the PoolScreen 2.0 program 
(University of Alabama at Birmingham, Birmingham, AL, 
USA) (33–35).
Results
A total of 74 trapping events occurred at 38 different 
homestead locations in the study villages. Because of the 
annual drought, no mosquitoes were recovered in the traps 
set in August. Overall, 12,080 mosquitoes were collected: 
9,701 mosquitoes during the 7 trapping nights in Decem-
ber (December 12–19, 2006) and 2,379 mosquitoes during 
the 6 trapping nights in January (January 19–26, 2007). 
The most abundant mosquitoes trapped were of the genus 
Culex. For the entire trapping period 7,853 Culex spp., 
3,488 Anopheles spp., 682 Mansonia spp., and 57 Aedes 
spp. mosquitoes were trapped and identiﬁ  ed. Traps caught 
an average of 199 mosquitoes per trap, with an average of 
141 Culex spp. mosquitoes. 
To estimate location-speciﬁ  c risk for arbovirus trans-
mission during the December 2006–January 2007 sampling 
period, 920 mosquitoes collected in the ﬁ  eld were pooled 
for PCR detection of RVFV and WNV. These 920 exo-
philic mosquitoes were trapped at 30 different homesteads 
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Table 1. Oligonucleotide primer pairs used in assay during Rift Valley fever outbreak, Kenya, 2006–2007* 
Target  Forward sequence, 5ƍ o 3ƍ  Reverse sequence, 5ƍ m 3ƍ 
Product size, 
bp 
GenBank 
accession no. 
Mosquito 18S rRNA  GATCAAGTGGAGGGCAAGTC  AAGGAGTAGCACCCGTGTTG  124  AB085210.1 
RVFV TGAAAATTCCTGAGACACATGG  ACTTCCTTGCATCATCTGATG  90  DQ375404.1 
WNV CAGACCACGCTACGGCG  CTAGGGCCGCGTGGG  103  AF196835.2 
*RVFV, Rift Valley fever virus; WNV, West Nile virus. RESEARCH
adjacent to animal structures, yielding 105 pools based on 
trap location (homestead) per trapping night with an aver-
age of 10 mosquitoes (range 1–12 mosquitoes) per pool. In 
23 Gumarey homesteads, 552 mosquitoes were trapped and 
divided into 65 total pools in the laboratory (1–12 individ-
ual mosquito legs/pool, based on trap night). A total of 368 
mosquitoes were trapped at 7 Sogan-Godud homesteads 
and divided into 40 pools for testing (1–11 individual mos-
quito legs/pool, based on trap night). Most mosquitoes test-
ed were morphologically identiﬁ  ed as Culex spp. (n = 654, 
71%) (Figure 3). The remaining mosquitoes were identi-
ﬁ  ed as Anopheles spp. (n = 107, 12%), Mansonia spp. (n = 
101, 11%), and Aedes spp. (n = 58, 6%). Synthesis of total 
cDNA was successful; 99% of samples amplifyed 18S, and 
the remaining 1% was removed from further testing.
In total, of the 105 trap-night pools, 18% (95% conﬁ  -
dence interval [CI] 11.3%–26.8%) had positive results by 
PCR for WNV and 22% (95% CI 14.5%–31.1%) for RVFV 
(Table 2). Of the 65 pools from Gumarey, 14% (95% CI 
6.5%–24.7%) and 30% (95% CI 18.6%–41.8%) had posi-
tive results for WNV and RVFV, respectively. Of the 40 
pools from Sogan-Godud, 25% (95% CI 12.7%–41.2%) 
and 10% (95% CI 2.8%–23.7%) had positive results for 
WNV and RVFV, respectively. A comparison of positive 
results for RVFV in mosquito pools across villages was sig-
niﬁ  cantly different (p = 0.0279); a comparison of positive 
results for WNV across village pools was not (p = 0.1932). 
Three percent of mosquito pools tested had positive results 
for both WNV and RVFV.
Figure 4 shows the area distribution of homesteads, 
mosquito traps, and local abundance of RVFV-positive 
and WNV-positive trap pools. When analyzed based on the 
30 homestead locations, 10 (33%; 95% CI 17.3%–52.8%) 
homesteads with tested mosquitoes were positive for 
WNV, versus 15 (50%; 95% CI 31.3–68.7%) for RVFV 
(Table 3). Most (5/7; 71%) Sogan-Godud homesteads were 
positive for WNV (95% CI 29.0%–96.3%), compared with 
5/23 (22%; 95% CI 7.5%–43.7%) for Gumarey, although 
MIRs did not differ (Table 3). Homestead WNV positivity 
signiﬁ  cantly differed between villages (p = 0.0256); RVFV 
positivity of homesteads did not (p = 1.000). RVFV home-
stead positivity rates were similar between the 2 locations; 
12/23 (52%; 95% CI 30.6–73.2) mosquito pools in Gumar-
ey homesteads had positive results, versus 3/7 (43%; 95% 
CI 9.9–81.6) in Sogan-Godud. 
In terms of the general population, by using geographic 
information systems analysis of spatially referenced census 
data (Figure 5), we conﬁ  rmed that >30% of Sogan residents 
and >40% of Gumarey residents lived within 100 meters 
of an identiﬁ  ed RVFV-positive mosquito trap site. Forty-
eight percent of Sogan residents lived within 100 meters of 
a WNV-positive trap site; only 19% of Gumarey residents 
lived within 100 meters of a WNV-positive site.
Of the mosquitoes trapped during this study, Culex 
spp. was the predominant genus, although Aedes spp., 
Anopheles spp., and Mansonia spp. mosquitoes were also 
recovered during nocturnal light trapping. In the pools 
that contained only 1 genus of mosquito, positivity var-
ied. A total of 63 pools were composed solely of Culex 
spp. mosquitoes (speciﬁ  cally  Cx. quinquefasciatus), 9 
of which were positive for RVFV. Additionally, 1 of 4 
pools containing only Aedes spp. mosquitoes were RVFV 
positive, 3 of 8 Anopheles spp.–only mosquito pools had 
positive results for RVFV, and 3 of 8 Mansonia spp.–only 
mosquito pools had positive results for RVFV. WNV-
positive pools composed of only 1 genus included 3 of 4 
Aedes spp.–only mosquito pools and 15 of 63 Culex spp.–
only mosquito pools. All Aedes spp. mosquitoes collected 
were trapped in December but were absent in the traps 
in January (Figure 3). The temporal distribution of these 
mosquitoes correlates with previous studies showing that 
Aedes spp. mosquitoes predominate in the initial weeks 
after substantial ﬂ  ooding and then curtail after the ﬁ  rst 
month of ﬂ  ooding, at which time Culex spp. and Anoph-
eles spp. mosquitoes emerge as the predominant species 
(17,36). It is believed that the dramatic proliferation of 
transovarially infected Aedes spp. mosquitoes immediate-
ly after ﬂ  ooding re-introduces virus into an epizootic/epi-
demic cycle, after which Culex spp. mosquitoes propagate 
the virus in an epizootic/endemic cycle among humans 
and animal species (17).
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Figure 2. PCR gel showing positive Rift Valley fever virus bands (90 
bp). Lane 1, molecular mass ladder; lane 2, Rift Valley fever virus 
MP-12 positive control; lane 3, negative control; lane 4, pool 103 
(positive); lane 5, pool 86 (negative); lane 6, pool 104 (negative); 
lane 7, pool 87 (negative); lane 8, pool 105 (positive).Arbovirus Prevalence in Mosquitoes, Kenya
Discussion
A substantial proportion of the mosquito population 
collected within our study area consisted of RVFV- or 
WNV-infected potential vectors. The close proximity of 
these infected mosquitoes to amplifying hosts and sus-
ceptible animals and humans during an RVFV epizootic/
epidemic warrants further investigation of transmission 
dynamics. RVFV RNA in mosquitoes collected within the 
area was high, and the substantial presence of WNV RNA 
in these mosquito samples was unexpected. The presence 
of WNV in mosquitoes from Sogan-Godud and Gumar-
ey in our study corroborates recent documentation of the 
widespread presence of WNV in Kenya and the ability of 
mosquito populations, including Cx. quinquefasciatus, to 
acquire and transmit WNV (23).
The previous isolation of WNV from male Culex 
spp. mosquitoes in Rift Valley Province suggests a natu-
ral transovarial transmission cycle among some mosquito 
vectors but is unlikely to contribute greatly to virus main-
tenance between enzootic periods (23). Additionally, al-
though human epidemics and outbreaks of WNV have not 
been reported, the presence of the virus in local mosquitoes 
suggests that the virus is maintained in a natural cycle yet 
to be elucidated and that the actual incidence of WNV in 
human populations in the region could be underestimated. 
Improved ﬁ  eld diagnostics are necessary for rapid and ac-
curate diagnosis of circulating arbovirus threats and expe-
dient translation into preventive public health practices.
The isolation of RVFV and WNV RNA from mosquito 
leg samples conﬁ  rms that these viruses were disseminated 
within the bodies of the mosquitoes tested. These results 
also conﬁ  rm that single mosquito leg samples are sufﬁ  cient 
for PCR/qRT-PCR detection of RVFV and WNV, respec-
tively. Positive results from testing of the mosquito legs 
also diminish concern about false-positive results from test-
ing whole mosquitoes, which might contain recent blood-
meals with substantial viral content. Our study conﬁ  rms 
that RVFV disseminates to the legs of wild Cx. quinquefas-
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Figure 3. Identiﬁ  cation of mosquitoes trapped, Gumarey and Sogan-Godud, Masalani Division of Ijara District, Kenya, 2006–2007. A) 
Mosquito species trapped during sampling effort. B) Mosquitoes trapped by date. Aedes spp. mosquitoes were found in traps only in 
December 2006 and Mansonia spp. mosquitoes only in January 2007. C) Temporal comparison of mosquitoes trapped in Gumarey. D) 
Mosquitoes trapped by study area, December 2006.RESEARCH
ciatus mosquitoes and suggests that these mosquitoes, pro-
miscuous feeders, could play a role in the maintenance or 
transmission of RVFV in disease-endemic regions (20,21). 
Other vector competence studies have shown that RVFV 
does disseminate in Cx. quinquefasciatus mosquitoes but 
have yet to show that they are efﬁ  cient vectors for RVFV 
(20,21,37). Although identiﬁ  cation of viral RNA in the 
legs of Cx. quinquefasciatus as well as the other mosqui-
toes tested supports dissemination of virus, no conclusions 
can be made from these results regarding the role of these 
mosquitoes in maintaining these arboviruses in this envi-
ronment or their ability to transmit virus. Additional studies 
are required to determine vector competence of Cx. quin-
quefasciatus and other mosquito species tested for these 
2 viruses.
During this RVFV outbreak, we documented >1 ar-
bovirus circulating in local mosquitoes. During an arbo-
virus outbreak, other viruses may be circulating concomi-
tantly without recognition and serve as alternative causes 
of fever. Additional arthropod surveillance studies during 
RVFV outbreaks in Kenya have found arboviruses in mos-
quitoes, including ﬂ  aviviruses and alphaviruses, which can 
cause febrile illness in humans (38). Because diseases from 
arboviral infections can be nonspeciﬁ  c in humans and ani-
mals, it is necessary, even during large outbreaks, to docu-
ment the true cause of disease with detailed testing. Cases 
of other arboviral infections could be missed if suspected 
cases are attributed to the epidemic arbovirus without ac-
curate diagnosis.
Although MIRs for RVFV were similar in the 2 vil-
lages studied, rural Gumarey was more likely to have 
RVFV-positive pools than was Sogan-Godud. This ﬁ  nding 
concurs with previous human seroprevalence studies that 
found that risk for being RVFV seropositive is 4× greater 
for those living in Gumarey than for those in Sogan-Godud 
(2). Gumarey residents were more likely to report greater 
contact with animals and mosquitoes (2). Continued re-
search to identify village level and landscape factors re-
sponsible for increased human transmission is necessary. 
Although RVFV can be transmitted to humans by the bite 
of an infected mosquito, alternative forms of human ex-
posure, such as aerosol and direct contact, may be more 
critical for transmission during epidemics (2,28,36). More 
research must be conducted to elucidate the most common 
and most effective routes of RVFV transmission to humans 
during epidemic and interepidemic periods.
Few research studies have documented the presence 
of WNV and the vectors responsible for its transmission 
in Kenya. The identiﬁ  cation of WNV in North Eastern 
Province indicates a greater prevalence of the virus than 
was expected. WNV has not been previously reported in 
mosquitoes from these 2 villages, and study results imply 
regional variance in infection rates. Further studies may 
elucidate a difference between these 2 villages with regard 
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Table 2. PCR results for RVFV and WNV in mosquito pools, by 
pool, Kenya, 2006–2007* 
Virus and location 
No. positive/ 
no. tested (%) 
MIR
estimate, %  95% CI 
Total 
  WNV   19/105 (18)  2.3 1.3–3.6 
 RVFV    23/105  (22)  2.8 1.7–4.2 
Gumarey 
  WNV   9/65 (14)  1.8 0.75–3.40 
 RVFV    19/65  (30)  3.9%  2.3–6.3 
Sogan-Godud 
  WNV   10/40 (25)  3.0%  1.4–5.7 
 RVFV    4/40  (10)  1.1%  0.29–2.90 
*RVFV, Rift Valley fever virus; WNV, West Nile virus; MIR, minimum 
infection rate; CI, confidence interval. 
Figure 4. Distribution of human population and infected and uninfected mosquitoes across the selected study areas, Gumarey and Sogan-
Godud, Masalani Division of Ijara District, Kenya. A) Area homestead locations (circles) and relative area density of human population 
(contours, 500-m kernel density; darker color indicates higher values). B) Study trap locations (triangles) and area density of mosquitoes 
(contours for average mosquitoes per trap, 500-m kernel density). C) Homestead locations of mosquito pools testing positive (white 
circles) and negative (black circles) for Rift Valley fever virus. Relative local density of positive pools per 500 m is indicated by contours. 
D) Homestead locations of mosquito pools testing positive (white circles) and negative (black circles) for West Nile virus. Relative density 
of positive pools is indicated by contours.Arbovirus Prevalence in Mosquitoes, Kenya
to resident reservoirs (birds) or undiscovered amplifying 
hosts, especially if data are collected during outbreak con-
ditions of ﬂ  ooding and mosquito proliferation. The spatial 
overlap of human population density with mosquito abun-
dance (Figure 4) and the proximity of humans to infected 
mosquitoes (Figure 5), suggest that RVFV and WNV trans-
mission during epizootic/epidemic periods could be high 
in both villages. Additional exposure-modifying factors, 
including the relative contribution of aerosol transmission 
of RVFV and the effects of housing construction, sleep and 
work habits, and the role of personal protective measures 
need to be further elucidated (2).
Our study has several limitations. Mosquito sampling 
during the outbreak was not stratiﬁ  ed, and pooling of col-
lected mosquitoes was not randomized (39). Mosquito sam-
pling was conducted only at homesteads where speciﬁ  c ani-
mals, those known to be reservoirs of RVFV, were housed 
closely with humans. This sampling method may have un-
derestimated the WNV MIR detected. This type of targeted 
sampling, however, can provide earlier detection of arbovi-
ruses and greater understanding of transmission and mainte-
nance factors of these viruses (39). Although only 920 mos-
quitoes were tested for WNV and RVFV, a fraction of the 
total mosquito population collected, it has been shown that 
testing of mosquito pools versus testing of all samples can 
yield suitable results, thereby conserving time and resources 
(39,40). The choice of screening pools for arboviruses of-
fers many beneﬁ  ts, especially during an outbreak. The po-
tentially limiting factors of cost and time are avoided, while 
mosquito positivity is accurately identiﬁ  ed (33,39).
In conclusion, we found high MIR for RVFV and WNV 
for many mosquitoes, some potentially efﬁ  cient vectors, 
in our study region during the 2006–07 RVF outbreak in 
northeastern Kenya. MIRs did not differ between villages, 
although RVFV pool positivity and human seroprevalence 
(as measured in a previous homestead-based study during 
an interepidemic period) were higher in the rural village of 
Gumarey (2). Our data demonstrate the local abundance of 
mosquitoes infected with arboviruses in Kenya and high-
lights simultaneous arbovirus circulation. A greater under-
standing of how these arboviruses are maintained in nature 
will improve targeted prevention in regions where disease 
is endemic and curtail introduction to new areas. Our cur-
rent inability to quickly detect arboviral infections in en-
demic communities has led to inaccurate risk assessments, 
underdiagnosis of clinical cases, and ineffective control 
measures. Better detection methods in vector, animal, and 
human populations and recognition of arboviral risk zones 
and circulation may alter current perceptions about these 
diseases. These methods could also lead to improved sur-
veillance and better estimates of the true impact of arbovi-
ral disease on animal and human populations. 
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